Cargando…
Selective potassium uptake via biocompatible zeolite–polymer hybrid microbeads as promising binders for hyperkalemia
Patients with chronic kidney disease are at high risk of hyperkalemia that is associated with various life-threatening complications. Treatments primarily rely on orally administered potassium binding agents, along with low curative effects and various side effects. Herein, direct serum potassium up...
Autores principales: | Wang, Zhoujun, Sun, Wei, Wei, Zhiwei, Bao, Jianxu, Song, Xin, Li, Yupei, Ji, Haifeng, Zhang, Jue, He, Chao, Su, Baihai, Zhao, Weifeng, Zhao, Changsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498761/ https://www.ncbi.nlm.nih.gov/pubmed/32995679 http://dx.doi.org/10.1016/j.bioactmat.2020.08.032 |
Ejemplares similares
-
A randomized study to compare oral potassium binders in the treatment of acute hyperkalemia
por: Cañas, Alejandro E., et al.
Publicado: (2023) -
Advances in Enhancing Hemocompatibility of Hemodialysis Hollow-Fiber Membranes
por: Ji, Haifeng, et al.
Publicado: (2023) -
Optimization of RAASi Therapy with New Potassium Binders for Patients with Heart Failure and Hyperkalemia: Rapid Review and Meta-Analysis
por: Montagnani, Andrea, et al.
Publicado: (2021) -
Hyperkalemia and the Use of New Potassium Binders a Single Center Experience from Vestfold Norway (The PotBind Study)
por: Bjune, Thea, et al.
Publicado: (2023) -
Constipation as a Drug-Related Adverse Effect in Patients with Hyperkalemia: Sodium Zirconium Cyclosilicate versus Conventional Potassium Binders
por: Hida, Yuki, et al.
Publicado: (2023)